CAR T Cell Therapy in Cancer Forum

Thursday, March 7, 2019

8:25-8:50 AM Overview of Program
Stephen J. Forman, MD

8:30 – 8:50 AM   CAR T Cells – A Personalized Attack on Cancer
Xiuli Wang, PhD 

8:50 – 9:10 AM CAR T Cell Therapy for Acute Myeloid Leukemia (AML)
Lihua Elizabeth Budde, MD, PhD

 9:10 – 9:30 AM CAR T Cell Therapy for Acute Lymphoblastic Leukemia (ALL)
Samer Khaled, MD

10:00 – 10:20 AM CAR T Cell Therapy for Chronic Lymphocytic Leukemia (CLL) & Central Nervous System (CNS) Lymphoma
 Tanya Siddiqi, MD

10:20 – 10:40 AM  CAR T Cell Therapy for Diffuse Large B-Cell Lymphoma
Alex Herrera, MD

10:40 – 11:00 AM  CAR T Cell Therapy Post Autologous Transplant
Leslie Popplewell, MD

11:00 – 11:20 AM CAR T Cell Therapy For Relapsed Myeloma
 Myo Htut, MD 

12:55 – 1:15 PM  CAR T Cell Therapy Related Toxicities
Lihua Elizabeth Budde, MD, PhD

1:15 – 1:35 PM Infectious Complications in Recipients of CAR T Cells: Epidemiology and Prevention
Sanjeet Dadwal, MD

1:35 – 1:55 PM  Diagnosis and Management of Cardiovascular Complications
Faizi A. Jamal, MD

1:55 – 2:15 PM  CAR T Cell Related Neurotoxicity
Neal Prakash, MD, PhD, FAAN

2:15 – 2:35 PM   Current Use of FDA Approved CAR T Cell Products
 Samer Khaled, MD   

3:05 – 3:25 PM Progress and Challenges in CAR T Cell Therapy for Brain Tumors
Christine E. Brown, PhD

3:25 – 3:45 PM  Targeting Brain Metastases from HER2-Positive Breast Cancer with Intraventricularly Administered CAR T Cells
Jana Portnow, MD

3:45 – 4:05 PM CAR T Cell Therapy for Prostate Cancer and Beyond
Saul Priceman, PhD

4:05 – 4:25 PM CAR T Cell Management from a Nursing Perspective
Jennifer Peterson, MSN, RN

4:25 – 4:45 PM  Moving Natural Killer Cell CARs to the Clinic
Michael A. Caligiuri, MD

4:45 – 5:05 PM Future Directions
Stephen J. Forman, MD

AJCC Cancer Staging Form Supplement for CAR T

Download AJCC Cancer Staging Forms by clicking on the link below:

https://cancerstaging.org

City of Hope may find it necessary to substitute faculty with comparable expertise on those rare occasions necessitated by illness, unforeseen scheduling conflicts or extraordinary occurrences.